|
CPSF7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.462000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.079700E-03 |
| Normal-vs-Stage2 |
8.531800E-01 |
| Normal-vs-Stage3 |
2.630600E-01 |
| Normal-vs-Stage4 |
1.058260E-02 |
| Stage1-vs-Stage2 |
2.108600E-01 |
| Stage1-vs-Stage3 |
5.826200E-01 |
| Stage1-vs-Stage4 |
5.452600E-01 |
| Stage2-vs-Stage3 |
5.661600E-01 |
| Stage2-vs-Stage4 |
2.042400E-01 |
| Stage3-vs-Stage4 |
3.819000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.112000E-02 |
| Normal-vs-AfricanAmerican |
2.374000E-01 |
| Normal-vs-Asian |
5.956500E-02 |
| Caucasian-vs-AfricanAmerican |
5.959200E-01 |
| Caucasian-vs-Asian |
6.446000E-01 |
| AfricanAmerican-vs-Asian |
5.142400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.443000E-03 |
| Normal-vs-Female |
9.451400E-01 |
| Male-vs-Female |
4.834300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.762200E-02 |
| Normal-vs-Extreme_Weight |
3.220500E-03 |
| Normal-vs-Obese |
5.804400E-01 |
| Normal-vs-Extreme_Obese |
3.375100E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.220200E-01 |
| Normal_Weight-vs-Obese |
3.608200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.734200E-01 |
| Extreme_Weight-vs-Obese |
5.964200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.567800E-01 |
| Obese-vs-Extreme_Obese |
4.658400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.692200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.148000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.201740E-03 |
| Normal-vs-Age(81-100Yrs) |
1.741780E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.950400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.142400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.378400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.290070E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.316100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.424600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.124250E-01 |
| Normal-VS-Type2 PRCC |
2.22389999999795E-05 |
| Normal-VS-KIRP CIMP |
7.099400E-01 |
| Normal-VS-Unclassified PRCC |
9.468200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.539900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.456400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.707000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.766350E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.717900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.462200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.243600E-03 |
| Normal-vs-N1 |
6.533200E-01 |
| Normal-vs-N2 |
1.578260E-03 |
| N0-vs-N1 |
5.284100E-02 |
| N0-vs-N2 |
2.760200E-01 |
| N1-vs-N2 |
1.344160E-01 |
|
|
